Together, BM microenvironment rendered K562 cells drug resistance through activating Hh signaling, however, OAG could overcome IM resistance of CML cells through inhibiting Hh-BCR-ABL axis in vitro and in vivo. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.